glp-1 news october 9 2025 Agonists Market Report 2025-2033, By Product, Molecule, and Geo GLP-1 Market Overview 2025

Discover how GLP-1 agonists help improve cardiovascular outcomes independently of glucose control.

2020 global estimate and projected number of adults through 2035 with an overweight BMI [1]. Obesity is a significant independent risk factor contributing to numerous chronic conditions, including diabetes, hypertension, cardiovascular disease, and obstructive sleep apnea syndrome

2 Billion AFU Blend Per Serving with Akkermansia for Balanced Gut Environment: Each serving of Akkermansia Probiotic for Weight Loss features 2 Billion AFU per serving of active cultures, selected to help support inner balance and daily wellness

Will GLP-1 medications show up on blood tests

Promotes a healthy blood sugar response*: Reducose slows down the breakdown of carbs to reduce post-meal glucose spikes by up to 40%, while Feiolix supports insulin sensitivity and glucose metabolism.

An analysis of PBM tension, the Newkirk litigation, Anthems GLP-1 coverage issues, and emerging risks in pharmacy benefit plan design.